Characteristics and Outcomes for Parapharyngeal Metastases Characteristics and Outcomes for Parapharyngeal Metastases
A new study looks at the clinical characteristics of patients with parapharyngeal metastases and survival after receiving radioiodine therapy.Clinical Endocrinology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - July 10, 2023 Category: Consumer Health News Tags: Hematology-Oncology Journal Article Source Type: news
Don't Be Afraid of Weight Gain With Hyperthyroid Treatment Don't Be Afraid of Weight Gain With Hyperthyroid Treatment
A large study shows highest weight gain risk is with thyroidectomy, and radioiodine therapy is linked to better survival.Medscape Medical News (Source: Medscape Pharmacist Headlines)
Source: Medscape Pharmacist Headlines - October 21, 2022 Category: Drugs & Pharmacology Tags: Diabetes & Endocrinology News Source Type: news
Empiric Radioiodine for Hyperthyroidism Empiric Radioiodine for Hyperthyroidism
Learn more about empiric radioiodine therapy and the role of theranostics in hyperthyroidism.Clinical Endocrinology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - August 11, 2022 Category: Consumer Health News Tags: Diabetes & Endocrinology Journal Article Source Type: news
Metastatic DTC Unaffected by Mode of Preparation for RAI Metastatic DTC Unaffected by Mode of Preparation for RAI
The results of this study suggest the mode of preparation for radioiodine therapy does not impact outcomes among patients with metastatic differentiated thyroid cancer.Journal of the Endocrine Society (Source: Medscape Radiology Headlines)
Source: Medscape Radiology Headlines - May 16, 2022 Category: Radiology Tags: Hematology-Oncology Journal Article Source Type: news
Radioiodine Therapy Reduces CTCs in Thyroid Cancer Radioiodine Therapy Reduces CTCs in Thyroid Cancer
A new study found a reduction of circulating tumor cell numbers in patients with differentiated thyroid cancer after radioiodine therapy. What are the implications?Clinical Endocrinology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - July 2, 2021 Category: Consumer Health News Tags: Ob/Gyn & Women ' s Health Journal Article Source Type: news
Radioiodine Therapy vs Ablation of Thyroid Nodules Radioiodine Therapy vs Ablation of Thyroid Nodules
How do these treatments compare in terms of nodule volume reduction and thyroid function normalization?Clinical Endocrinology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - April 29, 2019 Category: Consumer Health News Tags: Diabetes & Endocrinology Journal Article Source Type: news
Delayed Initial Radioiodine Therapy in Thyroid Cancer Delayed Initial Radioiodine Therapy in Thyroid Cancer
The initiating time of radioiodine therapy in differentiated thyroid cancer may impact the individual response to therapy.Clinical Endocrinology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - May 14, 2018 Category: Consumer Health News Tags: Diabetes & Endocrinology Journal Article Source Type: news
Early radiotherapy linked to better response after thyroidectomy
Research inClinical Endocrinology suggests that adults with differentiated thyroid cancer, who undergo thyroidectomy and start radioiodine therapy within the first three months after surgery, have better outcomes.Healio (Source: Society for Endocrinology)
Source: Society for Endocrinology - January 19, 2018 Category: Endocrinology Source Type: news
Radioiodine Therapy for Thyroid Cancer Doesn ’ t Up Stroke Risk
I - 131 therapy group showed no significantly higher risk of ischemic or hemorrhagic stroke (Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - August 19, 2017 Category: Cancer & Oncology Tags: Cardiology, Endocrinology, Family Medicine, Internal Medicine, Neurology, Oncology, ENT, Radiology, Journal, Source Type: news
Surgically Ablated Thyroid Cancer Does Not Need Adjuvant RAISurgically Ablated Thyroid Cancer Does Not Need Adjuvant RAI
In patients with intermediate-risk thyroid cancer that has been surgically ablated, adjuvant radioiodine therapy may not be necessary. Clinical Endocrinology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - April 12, 2016 Category: Consumer Health News Tags: Hematology-Oncology Journal Article Source Type: news
miR-339-5p modulates NIS-mediated RAIU
Na+/I− symporter (NIS)-mediated radioiodide uptake (RAIU) serves as the basis for targeted ablation of thyroid cancer remnants. However, many thyroid cancer patients have reduced NIS expression/function. microRNAs (miRs) have emerged as a promising therapeutic method; Lakshmanan and colleagues make the first report to demonstrate that hNIS-mediated RAIU can be modulated by miRs, and that the same miRs may also play roles in thyroid malignancy. Accordingly, miRs may serve to halt the progression of thyroid cancer and to enhance the efficacy of radioiodine therapy.
Read the full article at Lakshmanan et al. (2015)...
Source: Society for Endocrinology - January 26, 2015 Category: Endocrinology Source Type: news
New guidance on radioiodine therapy use after radiographic studies
Researchers have provided new evidence that could act as a guide for the use of radioiodine therapy after patients have undergone radiographic imaging studies that use iodine as a contrasting agent. (Source: MedWire News - Oncology)
Source: MedWire News - Oncology - May 1, 2013 Category: Cancer & Oncology Source Type: news